Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy

被引：2
|
作者：
Moyenuddin, M
Ohl, CA
Williamson, JC
Peacock, JE
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Infect Dis Sect, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Baptist Med Ctr, Dept Pharm, Winston Salem, NC 27157 USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 01期
关键词：
disseminated; oxacillin-resistant Staphylococcus aureus;
D O I：
10.1093/jac/dkg025
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：202 / 203
页数：2
相关论文
共 50 条
  • [1] VANCOMYCIN THERAPY OF OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS
    KLASTERSKY, J
    COPPENS, L
    VANDERAUWERA, P
    MEUNIERCARPENTIER, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (04) : 361 - 367
  • [2] Quinupristin/Dalfopristin in Vancomycin-Resistant Staphylococcus aureus Endophthalmitis
    Stroh, Edward M.
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (10) : 1323 - 1324
  • [3] Enterococcus faecium cholangitis resistant to vancomycin and quinupristin-dalfopristin
    Maseda, E
    Uña, R
    Ureta, P
    Royo, C
    [J]. MEDICINA CLINICA, 2002, 119 (07): : 276 - 277
  • [4] Efficacy of quinupristin-dalfopristin against methicillin-resistant Staphylococcus aureus and vancomycin-insensitive S-aureus in a model of hematogenous pulmonary infection
    Yanagihara, K
    Okada, M
    Fukuda, Y
    Imamura, Y
    Kaneko, Y
    Ohno, H
    Higashiyama, Y
    Miyazaki, Y
    Tsukamoto, K
    Hirakata, Y
    Tomono, K
    Kadota, JI
    Tashiro, T
    Murata, I
    Kohno, S
    [J]. CHEMOTHERAPY, 2004, 50 (05) : 260 - 264
  • [5] Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection
    Saleh-Mghir, A
    Ameur, N
    Muller-Serieys, C
    Ismael, F
    Lemaitre, F
    Massias, L
    Feger, C
    Bléton, R
    Crémieux, AC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) : 1122 - 1124
  • [6] Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin
    Fuller, RE
    Drew, RH
    Perfect, JR
    [J]. PHARMACOTHERAPY, 1996, 16 (04): : 584 - 592
  • [7] Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus:: Experimental rabbit endocarditis study
    Batard, E
    Jacqueline, C
    Boutoille, D
    Hamel, A
    Drugeon, HB
    Asseray, N
    Leclercq, R
    Caillon, J
    Potel, G
    Bugnon, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2174 - 2178
  • [8] Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
    Drew, RH
    Perfect, JR
    Srinath, L
    Kurkimilis, E
    Dowzicky, M
    Talbot, GH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 775 - 784
  • [9] Detection of quinupristin-dalfopristin resistance in methicillin-resistant Staphylococcus aureus in South India
    Kali, Arunava
    Stephen, Selvaraj
    Umadevi, Sivaraman
    Kumar, Shailesh
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (01) : 73 - 74
  • [10] Oxacillin-resistant phenotypes of Staphylococcus aureus
    Haberberger, RL
    Kallen, AJ
    Driscoll, TJ
    Wallace, MR
    [J]. LABORATORY MEDICINE, 1998, 29 (05) : 302 - 305
12345